ResearchA Long-acting Naltrexone Implant (iSTEP-N) for Opioid Use Disorder: First-in-Human Phase I Trial
ResearchSuzetrigine as Part of Multimodal Therapy Enables Opioid-Free Recovery After Aesthetic or Reconstructive Procedures
ResearchA Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study of MR-107A-02 in the Treatment of Post-Surgical Dental Pain
ResearchMR-107A-02 in Acute Postoperative Pain Management Following Bunionectomy: Results from a Multicenter, Placebo- and Active-Controlled, Phase 3 Trial
Jul 30, 2026Original ArticlePhase 2b Trial of a Na<sub>V</sub>1.8 Inhibitor for Acute PainWritten by 1 Roon author & 6 others Via The New England Journal of Medicine
ResearchSuzetrigine, a Non-Opioid NaV1.8 Inhibitor With Broad Applicability for Moderate-to-Severe Acute Pain: A Phase 3 Single-Arm Study for Surgical or Non-Surgical Acute Pain
ResearchSuzetrigine, a Nonopioid NaV1.8 Inhibitor for Treatment of Moderate-to-Severe Acute Pain: Two Phase 3 Randomized Clinical Trials
ResearchComparative Assessment of Immunogenicity and Safety of Recombinant Influenza Vaccine in Children, Adolescents, and Adults: Results from a Phase 3, Immunobridging, Open-Label, Non-Randomised Study
ResearchComparison of the Pharmacokinetics of MR-107A-02, a Novel Fast-Absorbing Formulation of Meloxicam, Versus Standard Meloxicam Reference: A Phase I Study
ResearchComparison of the Efficacy of HSK3486 and Propofol for Induction of General Anesthesia in Adults: A Multicenter, Randomized, Double-blind, Controlled, Phase 3 Noninferiority Trial
ResearchClinical Validation of a Fast-Acting Acetaminophen: A Randomized, Active and Placebo Controlled Dental Pain Study
ResearchCPL-01, an Investigational Long-Acting Ropivacaine, Demonstrates Safety and Efficacy in Open Inguinal Hernia Repair
ResearchEfficacy, Safety, and Pharmacokinetics of CPL-01, an Investigational Long-Acting Ropivacaine, in Bunionectomy: Results of a Phase 2b Study